Funding Innovative Research: Clinical Trial Grant

Cannonball Kids’ cancer Foundation (CKc) prioritizes funding clinical trials, research that is nearing translation to a clinical trial, and young investigator grants.
Grants funded by CKc must be innovative and provide better quality of life or symptom relief than current treatments.
When possible, CKc will prioritize funding research:

• with a focus on cancers that are under-funded or under-researched,with a focus on patient populations who are traditionally underserved.
• When possible, CKc will prioritize funding researchers of diverse backgrounds.

For CKc, “innovation” means the invention or application of novel methods or treatments, specifically treatments that have fewer side-effects than standard care, increase a child’s quality of life, and/or create an option for care where there otherwise were few or none (either on primary diagnosis, relapse, or for recalcitrant cancers).
Grant Program: Clinical Trial
Award Amount & Duration:

• $200,000 over 3 years
• Program Specific Eligibility Criteria

PI must hold an academic appointment at the Assistant Professor level or higherPreclinical studies must be completeIf an FDA Investigational New Drug (IND) application is necessary for the proposed clinical study, the IND application should already have passed FDA initial review and be activeIf the PI has recruited additional patient enrollment sites, local IRB approval must be obtained for each site.
Program Specific Evaluation Criteria
How many treatment options would this study provide for children?How accessible is this study for children and families to access?